range of vacancies scattered throughout the UK. Why work for Pertemps Medical? Pertemps Medical have been placing locum doctors for over 20... Medical...
across various departments to find out their pharmaceutical requirements Non-medical prescribing would be advantageous Benefits... for you' reward platform - discount and cashback for over 1000 retailers Free Bupa wellness screening Private medical insurance...
processes, systems, and procedures to ensure Arvato conforms to all aspects of Quality within Pharmaceuticals and medical... You will be an experienced RP or RPI who has worked within the medical devices and pharmaceutical vertical. Trained in the requirements laid...
We are inviting applications for the position of Surgery - ENT (Spec. Reg). We are looking for candidates with immediate availability for Spec. Reg grade Doctors specialising in Surgery - ENT. This job is located in West Midlands, starting ...
We are inviting applications for the position of Medicine - General Medicine (StR Higher). We are looking for candidates with immediate availability for StR Higher grade Doctors specialising in Medicine - General Medicine. This job is locat...
SK Finance's proposed IPO is a combination of a fresh issue of equity shares worth ₹500 crore and an OFS of up to ₹1,700 crore by promoters and investor shareholders Continue Reading »
Emudhra, a leading certifying authority in India, has seen its stock value surge by 245% in the past year, reaching ₹738.40. Centrum Broking in its recent note revised its price target price on the stock to ₹832 apiece. Reflecting on a strong spike in the share price, it adjusted its rating. Continue Reading »
Post FY24 results, most brokerage houses have kept their target price for Tata Chemicals at least 10% lower than the current market price Continue Reading »
With the 2024 general elections in India ongoing, investors are preparing for market volatility as Prime Minister Narendra Modi seeks a third term. Analysts suggest different strategies, from increasing equity exposure to adding gold and long-tenure debt to portfolios. Continue Reading »
Top Gainers and Losers Today : The Sensex gained 128.33 points, or 0.17, to settle at 74482.78, while the Nifty gained 43.35 points, or 0.19, to close at 22604.85. Continue Reading »
The marketing segment failed to compensate for the weak showing by the refining business, leading to muted Q4 results. And according to analysts at Kotak Institutional Equities, oil marketing companies are in for a dismal Q1FY25. Continue Reading »
Stock market today: Sensex closed with a gain of 128 points, or 0.17 per cent, at 74,611.11 while the Nifty settled at 22,648.20, up 43 points, or 0.19 per cent. Continue Reading »
IndiaMART InterMESH shares surged 10% on strong Q4 results despite target price cuts. Stock hit day's high of ₹2,913, up 21.6% from 52-week low. Company's net profit rose 79% YoY in Q4FY24 to ₹99.6 crore. Continue Reading »